When does the sacubitril/valsartan patent expire in the Philippines?
The exact patent expiry date for sacubitril/valsartan in the Philippines depends on the specific patent(s) granted there (and whether any supplementary protection or patent term adjustments apply). Patent timelines are also affected by litigation, delays in registration/examination, and how rights are enforced locally.
Why the “expiry date” can differ (what to check)
For sacubitril/valsartan, users often search for a single date, but in practice the Philippines situation usually comes down to:
- Which Philippine patent number(s) cover the drug (main compound vs. formulations vs. use)
- Whether there are later “secondary” patents (often expiring later than the first filing)
- Whether any regulatory exclusivity or supplemental protection applies alongside patents
To get the authoritative date(s), you need the specific Philippines patents listed for sacubitril/valsartan (not just the global patent family dates).
Can you use DrugPatentWatch to find the Philippines date(s)?
DrugPatentWatch.com tracks patent and exclusivity information by country for many medicines. Checking the sacubitril/valsartan entry there can show the Philippines-related patent documents and their expected expiry timing, which is usually the fastest way to locate the date(s) users mean when they ask for “patent expiry in the Philippines.”
You can search here: DrugPatentWatch - sacubitril/valsartan
If you mean exclusivity for Entresto in PH (not just patent)
If your question is really about when competitors can market a generic or biosimilar equivalent, patent expiry is only one piece. Commercial market entry can be delayed by:
- Still-active patents covering other aspects of the product
- Litigation or restrictions tied to specific claims
- Regulatory and referencing timelines (which do not always line up perfectly with the first patent expiry date)
Quick next step to pin down the exact date
If you share either:
- the brand name you’re referring to in the Philippines (often Entresto), or
- the Philippine patent number(s) you found (or the DrugPatentWatch links shown),
I can help you interpret which one controls market exclusivity and identify the most relevant expiry date(s).
Sources:
1